Ambica Agarbathies Aroma & Industries Limited
Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.BO) Stock Competitors & Peer Comparison
See (AMBICAAGAR.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBICAAGAR.BO | ₹23.52 | -1.80% | 413.8M | 83.07 | ₹0.29 | N/A |
| HINDUNILVR.BO | ₹2,194.00 | -2.65% | 5.2T | 48.14 | ₹46.24 | +1.93% |
| HINDUNILVR.NS | ₹2,194.60 | -2.68% | 5.2T | 51.81 | ₹42.96 | +1.93% |
| GODREJCP.BO | ₹1,081.35 | -4.47% | 1.1T | 62.70 | ₹17.81 | +1.79% |
| GODREJCP.NS | ₹1,080.30 | -4.60% | 1.1T | 62.80 | ₹17.78 | +1.79% |
| MARICO.NS | ₹778.00 | -0.11% | 1T | 59.26 | ₹13.25 | +1.34% |
| MARICO.BO | ₹777.90 | -0.22% | 1T | 59.48 | ₹13.20 | +1.34% |
| DABUR.BO | ₹466.65 | -4.35% | 849.4B | 46.18 | ₹10.37 | +1.67% |
| DABUR.NS | ₹466.70 | -4.35% | 848.9B | 46.06 | ₹10.39 | +1.67% |
| COLPAL.NS | ₹2,156.30 | -2.01% | 599.6B | 45.27 | ₹48.70 | +2.31% |
Stock Comparison
AMBICAAGAR.BO vs HINDUNILVR.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, HINDUNILVR.BO has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while HINDUNILVR.BO trades at ₹2,194.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas HINDUNILVR.BO's P/E ratio is 48.14. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HINDUNILVR.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to HINDUNILVR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HINDUNILVR.BO's competition here
AMBICAAGAR.BO vs HINDUNILVR.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, HINDUNILVR.NS has a market cap of 5.2T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while HINDUNILVR.NS trades at ₹2,194.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas HINDUNILVR.NS's P/E ratio is 51.81. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HINDUNILVR.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to HINDUNILVR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HINDUNILVR.NS's competition here
AMBICAAGAR.BO vs GODREJCP.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, GODREJCP.BO has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while GODREJCP.BO trades at ₹1,081.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas GODREJCP.BO's P/E ratio is 62.70. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GODREJCP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GODREJCP.BO's competition here
AMBICAAGAR.BO vs GODREJCP.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, GODREJCP.NS has a market cap of 1.1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while GODREJCP.NS trades at ₹1,080.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas GODREJCP.NS's P/E ratio is 62.80. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GODREJCP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GODREJCP.NS's competition here
AMBICAAGAR.BO vs MARICO.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, MARICO.NS has a market cap of 1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while MARICO.NS trades at ₹778.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas MARICO.NS's P/E ratio is 59.26. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to MARICO.NS's ROE of +0.40%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to MARICO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check MARICO.NS's competition here
AMBICAAGAR.BO vs MARICO.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, MARICO.BO has a market cap of 1T. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while MARICO.BO trades at ₹777.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas MARICO.BO's P/E ratio is 59.48. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to MARICO.BO's ROE of +0.40%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to MARICO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check MARICO.BO's competition here
AMBICAAGAR.BO vs DABUR.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, DABUR.BO has a market cap of 849.4B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while DABUR.BO trades at ₹466.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas DABUR.BO's P/E ratio is 46.18. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to DABUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check DABUR.BO's competition here
AMBICAAGAR.BO vs DABUR.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, DABUR.NS has a market cap of 848.9B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while DABUR.NS trades at ₹466.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas DABUR.NS's P/E ratio is 46.06. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to DABUR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check DABUR.NS's competition here
AMBICAAGAR.BO vs COLPAL.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, COLPAL.NS has a market cap of 599.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while COLPAL.NS trades at ₹2,156.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas COLPAL.NS's P/E ratio is 45.27. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to COLPAL.NS's ROE of +0.81%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to COLPAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check COLPAL.NS's competition here
AMBICAAGAR.BO vs COLPAL.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, COLPAL.BO has a market cap of 599.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while COLPAL.BO trades at ₹2,154.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas COLPAL.BO's P/E ratio is 45.08. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to COLPAL.BO's ROE of +0.81%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to COLPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check COLPAL.BO's competition here
AMBICAAGAR.BO vs PGHH.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, PGHH.NS has a market cap of 353.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while PGHH.NS trades at ₹10,604.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas PGHH.NS's P/E ratio is 49.45. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PGHH.NS's ROE of +1.01%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PGHH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PGHH.NS's competition here
AMBICAAGAR.BO vs PGHH.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, PGHH.BO has a market cap of 353.1B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while PGHH.BO trades at ₹10,599.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas PGHH.BO's P/E ratio is 49.14. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PGHH.BO's ROE of +1.01%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PGHH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PGHH.BO's competition here
AMBICAAGAR.BO vs GILLETTE.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, GILLETTE.BO has a market cap of 263.9B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while GILLETTE.BO trades at ₹8,020.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas GILLETTE.BO's P/E ratio is 49.42. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GILLETTE.BO's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GILLETTE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GILLETTE.BO's competition here
AMBICAAGAR.BO vs GILLETTE.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, GILLETTE.NS has a market cap of 263.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while GILLETTE.NS trades at ₹8,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas GILLETTE.NS's P/E ratio is 49.48. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to GILLETTE.NS's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to GILLETTE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check GILLETTE.NS's competition here
AMBICAAGAR.BO vs EMAMILTD.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, EMAMILTD.BO has a market cap of 200.2B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while EMAMILTD.BO trades at ₹443.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas EMAMILTD.BO's P/E ratio is 25.20. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to EMAMILTD.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to EMAMILTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check EMAMILTD.BO's competition here
AMBICAAGAR.BO vs EMAMILTD.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, EMAMILTD.NS has a market cap of 200.1B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while EMAMILTD.NS trades at ₹443.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas EMAMILTD.NS's P/E ratio is 25.18. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to EMAMILTD.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to EMAMILTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check EMAMILTD.NS's competition here
AMBICAAGAR.BO vs CUPID.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, CUPID.NS has a market cap of 108.2B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while CUPID.NS trades at ₹91.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas CUPID.NS's P/E ratio is 130.58. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CUPID.NS's ROE of +0.24%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to CUPID.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CUPID.NS's competition here
AMBICAAGAR.BO vs CUPID.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, CUPID.BO has a market cap of 108.1B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while CUPID.BO trades at ₹91.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas CUPID.BO's P/E ratio is 128.85. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CUPID.BO's ROE of +0.24%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to CUPID.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CUPID.BO's competition here
AMBICAAGAR.BO vs HONASA.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, HONASA.NS has a market cap of 94.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while HONASA.NS trades at ₹286.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas HONASA.NS's P/E ratio is 60.84. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HONASA.NS's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to HONASA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HONASA.NS's competition here
AMBICAAGAR.BO vs HONASA.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, HONASA.BO has a market cap of 94.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while HONASA.BO trades at ₹287.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas HONASA.BO's P/E ratio is 60.93. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HONASA.BO's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to HONASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HONASA.BO's competition here
AMBICAAGAR.BO vs JYOTHYLAB.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, JYOTHYLAB.BO has a market cap of 89.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while JYOTHYLAB.BO trades at ₹241.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas JYOTHYLAB.BO's P/E ratio is 26.23. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JYOTHYLAB.BO's ROE of +0.18%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to JYOTHYLAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JYOTHYLAB.BO's competition here
AMBICAAGAR.BO vs JYOTHYLAB.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, JYOTHYLAB.NS has a market cap of 89.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while JYOTHYLAB.NS trades at ₹241.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas JYOTHYLAB.NS's P/E ratio is 26.22. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JYOTHYLAB.NS's ROE of +0.18%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to JYOTHYLAB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JYOTHYLAB.NS's competition here
AMBICAAGAR.BO vs BAJAJCON.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, BAJAJCON.NS has a market cap of 48.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while BAJAJCON.NS trades at ₹371.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas BAJAJCON.NS's P/E ratio is 31.94. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BAJAJCON.NS's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to BAJAJCON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BAJAJCON.NS's competition here
AMBICAAGAR.BO vs BAJAJCON.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, BAJAJCON.BO has a market cap of 48.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while BAJAJCON.BO trades at ₹372.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas BAJAJCON.BO's P/E ratio is 31.94. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BAJAJCON.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to BAJAJCON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BAJAJCON.BO's competition here
AMBICAAGAR.BO vs SHK.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, SHK.NS has a market cap of 18.6B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while SHK.NS trades at ₹129.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas SHK.NS's P/E ratio is 10.92. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to SHK.NS's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to SHK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check SHK.NS's competition here
AMBICAAGAR.BO vs ALLTIME.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, ALLTIME.NS has a market cap of 14.4B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while ALLTIME.NS trades at ₹209.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas ALLTIME.NS's P/E ratio is 40.29. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to ALLTIME.NS's ROE of +0.08%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to ALLTIME.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check ALLTIME.NS's competition here
AMBICAAGAR.BO vs BCLIND.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, BCLIND.NS has a market cap of 8.2B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while BCLIND.NS trades at ₹27.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas BCLIND.NS's P/E ratio is 6.97. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to BCLIND.NS's ROE of +0.14%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to BCLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check BCLIND.NS's competition here
AMBICAAGAR.BO vs KAYA.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, KAYA.NS has a market cap of 4.9B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while KAYA.NS trades at ₹312.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas KAYA.NS's P/E ratio is -5.64. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to KAYA.NS's ROE of +0.62%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to KAYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check KAYA.NS's competition here
AMBICAAGAR.BO vs KAYA.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, KAYA.BO has a market cap of 4.8B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while KAYA.BO trades at ₹310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas KAYA.BO's P/E ratio is -5.61. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to KAYA.BO's ROE of +0.62%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to KAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check KAYA.BO's competition here
AMBICAAGAR.BO vs ADORMUL.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to ADORMUL.BO's ROE of -0.32%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to ADORMUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check ADORMUL.BO's competition here
AMBICAAGAR.BO vs PCCOSMA.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, PCCOSMA.BO has a market cap of 910M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while PCCOSMA.BO trades at ₹335.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas PCCOSMA.BO's P/E ratio is 11.35. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PCCOSMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PCCOSMA.BO's competition here
AMBICAAGAR.BO vs JHS.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, JHS.BO has a market cap of 786.7M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while JHS.BO trades at ₹8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas JHS.BO's P/E ratio is -9.89. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JHS.BO's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to JHS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JHS.BO's competition here
AMBICAAGAR.BO vs JHS.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, JHS.NS has a market cap of 770.4M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while JHS.NS trades at ₹8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas JHS.NS's P/E ratio is -14.29. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to JHS.NS's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to JHS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check JHS.NS's competition here
AMBICAAGAR.BO vs STDSFAC.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, STDSFAC.BO has a market cap of 433.5M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while STDSFAC.BO trades at ₹51.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas STDSFAC.BO's P/E ratio is N/A. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to STDSFAC.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to STDSFAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check STDSFAC.BO's competition here
AMBICAAGAR.BO vs AMBICAAGAR.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, AMBICAAGAR.NS has a market cap of 415.3M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while AMBICAAGAR.NS trades at ₹23.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas AMBICAAGAR.NS's P/E ratio is 32.68. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to AMBICAAGAR.NS's ROE of +0.01%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to AMBICAAGAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check AMBICAAGAR.NS's competition here
AMBICAAGAR.BO vs NKIND.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, NKIND.BO has a market cap of 383.7M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while NKIND.BO trades at ₹57.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas NKIND.BO's P/E ratio is -6.20. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NKIND.BO's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to NKIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NKIND.BO's competition here
AMBICAAGAR.BO vs NKIND.NS Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, NKIND.NS has a market cap of 372.6M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while NKIND.NS trades at ₹58.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas NKIND.NS's P/E ratio is -6.02. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NKIND.NS's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to NKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NKIND.NS's competition here
AMBICAAGAR.BO vs NUWAY.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, NUWAY.BO has a market cap of 354.6M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while NUWAY.BO trades at ₹37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas NUWAY.BO's P/E ratio is 14.40. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to NUWAY.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to NUWAY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check NUWAY.BO's competition here
AMBICAAGAR.BO vs PAOS.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, PAOS.BO has a market cap of 330.5M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while PAOS.BO trades at ₹51.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas PAOS.BO's P/E ratio is -17.08. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PAOS.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to PAOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PAOS.BO's competition here
AMBICAAGAR.BO vs SATTVASUKU.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, SATTVASUKU.BO has a market cap of 280M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while SATTVASUKU.BO trades at ₹0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas SATTVASUKU.BO's P/E ratio is -73.00. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to SATTVASUKU.BO's ROE of +0.12%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to SATTVASUKU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check SATTVASUKU.BO's competition here
AMBICAAGAR.BO vs PARMCOS-B.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, PARMCOS-B.BO has a market cap of 169.9M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while PARMCOS-B.BO trades at ₹34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas PARMCOS-B.BO's P/E ratio is 166.67. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to PARMCOS-B.BO's ROE of +0.00%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to PARMCOS-B.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check PARMCOS-B.BO's competition here
AMBICAAGAR.BO vs HIPOLIN.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, HIPOLIN.BO has a market cap of 156.8M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while HIPOLIN.BO trades at ₹50.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas HIPOLIN.BO's P/E ratio is -5.01. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to HIPOLIN.BO's ROE of -0.35%. Regarding short-term risk, AMBICAAGAR.BO is less volatile compared to HIPOLIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check HIPOLIN.BO's competition here
AMBICAAGAR.BO vs CORNE.BO Comparison March 2026
AMBICAAGAR.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.BO stands at 413.8M. In comparison, CORNE.BO has a market cap of 50.2M. Regarding current trading prices, AMBICAAGAR.BO is priced at ₹23.52, while CORNE.BO trades at ₹9.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.BO currently has a P/E ratio of 83.07, whereas CORNE.BO's P/E ratio is -5.91. In terms of profitability, AMBICAAGAR.BO's ROE is +0.01%, compared to CORNE.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.BO is more volatile compared to CORNE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.BO.Check CORNE.BO's competition here